News – Endpoints News

SIGN UP

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

4 minutes ago

MarketingRx roundup: Pharmas double down on renewable energy; Bayer funds health equity research

52 minutes ago

CVS Health joins in on a new way for pharmacies to get paid for prescription drugs

1 hour ago

Biogen collaborator NeuroSense shares secondary PhIIb data for its ALS treatment

2 hours ago

AbbVie’s new AI deal; Roche's PhIII win in breast cancer; SpringWorks to raise $275M

2 hours ago

Obesity deals come into focus after Roche shells out $2.7B for Carmot

2 hours ago

Scoop: Infectious disease biotech eyes $25M Series A to advance antibody for chronic lung infection

2 hours ago

Bausch Health’s Salix initiates first awareness day for opioid-induced constipation

3 hours ago

Boehringer looks 'beyond stable' to display the everyday realities of life with schizophrenia

3 hours ago

BIO names its vice chair and Amicus founder John Crowley as next CEO

4 hours ago

Lilly’s Verzenio just misses the mark on overall survival in PhIII breast cancer study

5 hours ago

Travere plans to lay off 20% of workforce as it focuses on full approval for kidney disease drug

6 hours ago

J&J promises 20 new drugs to back pharma growth through end of decade, as John Reed shares his plans

6 hours ago

Exclusive: Funding for women’s health startups is up more than 300% over the last 5 years

6 hours ago

Exclusive: Gary Glick’s Odyssey raises $101M Series C as first immunology drugs approach the clinic

6 hours ago

A CAR-T therapy invented at Seattle Children’s was never approved for kids. Now the hospital is launching its own ...

6 hours ago

CRISPR reprioritizes CAR-T pipeline with cuts, expands into autoimmune disease as US decision for exa-cel looms

6 hours ago

Another Flagship-founded biotech shutters as Axcella liquidates, ending long Covid plans

10 hours ago

Sanofi forms drug discovery pact with French startup Aqemia en route to ‘AI at scale’ ambition

11 hours ago

Alto Neuroscience unveils efficacy signal from PhIIa MDD trial with machine learning-identified biomarker

20 hours ago

23andMe said hackers accessed over 5 million members’ ancestry info

21 hours ago

Roche's BTK inhibitor put on partial hold over concerns about potential liver injury

22 hours ago

Endo hits the pool hall with Peyronie’s disease patients for latest campaign

22 hours ago

Fujifilm makes $200M manufacturing investment while Novartis pours $80M+ into China facility

22 hours ago

12 3 4 Next page Last page